Deciphering and imaging pathogenesis and cording of Mycobacterium abscessus in zebrafish embryos

Journal of Visualized Experiments

Volumn 2015, Issue 103, 2015, Pages

  Bernut, Audrey ^a,b   Dupont, Christian ^a,b   Sahuquet, Alain ^a   Herrmann, Jean Louis ^c   Lutfalla, Georges ^a   Kremer, Laurent ^a,b  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b UNIV MONTPELLIER   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Cording; Fluorescence microscopy; Infection; Innate immunity; Issue 103; Live imaging; Macrophage; Micro injection; Mycobacterium abscessus; Pathogenesis; Zebrafish

Indexed keywords

ANIMAL; FEMALE; FLUORESCENCE IMAGING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MACROPHAGE; MALE; MICROBIOLOGY; MYCOBACTERIUM; NONMAMMALIAN EMBRYO; PATHOGENICITY; PROCEDURES; TRANSGENIC ANIMAL; VIRULENCE; ZEBRA FISH;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; EMBRYO, NONMAMMALIAN; FEMALE; HOST-PATHOGEN INTERACTIONS; MACROPHAGES; MALE; MYCOBACTERIUM; OPTICAL IMAGING; VIRULENCE; ZEBRAFISH;

EID: 84942904785     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/53130     Document Type: Article

References (42)

1. Brown-Elliott, B. A., Wallace, R. J. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clinical Microbiology Reviews. 15, (4), 716-746 (2002).
2. Aitken, M. L., Limaye, A., et al. Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. American Journal of Respiratory and Critical Care Medicine.185, (2), 231-232 (2012).
3. Gilljam, M., Lindblad, A., Ridell, M., Wold, A. E., Welinder-Olsson, C. Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. Journal of Clinical Microbiology. 45, (5), 1497-1504 (2007).
4. Roux, A. -L., Catherinot, E., et al. Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France. Journal of Clinical Microbiology. 47, (12), 4124-4128 (2009).
5. Lee, M. -R., Cheng, A., et al. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates. The Journal of Antimicrobial Chemotherapy. 67, (1), 222-225 (2012).
6. Talati, N. J., Rouphael, N., Kuppalli, K., Franco-Paredes, C. Spectrum of CNS disease caused by rapidly growing mycobacteria. The Lancet Infectious Diseases. 8, (6), 390-398 (2008).
7. Medjahed, H., Gaillard, J. -L., Reyrat, J. -M. Mycobacterium abscessus: a new player in the mycobacterial field. Trends in Microbiology. 18, (3), 117-123 (2010).
8. Griffith, D. E., Girard, W. M., Wallace, R. J. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. The American Review of Respiratory Disease. 147, (5), 1271-1278 (1993).
9. Nessar, R., Cambau, E., Reyrat, J. M., Murray, A., Gicquel, B. Mycobacterium abscessus: a new antibiotic nightmare. The Journal of Antimicrobial Chemotherapy. 67, (4), 810-818 (2012).
10. Sanguinetti, M., Ardito, F., et al. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus a patient with cystic fibrosis. Journal of Clinical Microbiology. 39, (2), 816-819 (2001).
11. Griffith, D. E., Aksamit, T., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine. 175, (4), 367-416 (2007).
12. Howard, S. T., Rhoades, E., et al. Spontaneous reversion of Mycobacterium abscessus a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype. Microbiology (Reading, England). 152, (Pt 6), 1581-1590 (2006).
13. Chardi, A., Olivares, F., Byrd, T. F., Julián, E., Brambilla, C., Luquin, M. Demonstration of cord formation by rough Mycobacterium abscessus variants: implications for the clinical microbiology laboratory. Journal of Clinical Microbiology. 49, (6), 2293-2295 (2011).
14. Byrd, T. F., Lyons, C. R. Preliminary characterization of a Mycobacterium abscessus mutant in human and murine models of infection. Infection and Immunity. 67, (9), 4700-4707 (1999).
15. Catherinot, E., Clarissou, J., et al. Hypervariance of a rough variant of the Mycobacterium abscessus type strain. Infection and Immunity. 75, (2), 1055-1058 (2007).
16. Catherinot, E., Roux, A. -L., et al. Acute respiratory failure involving an R variant of Mycobacterium abscessus. Journal of Clinical Microbiology. 47, (1), 271-274 (2009).
17. Bernut, A., Le Moigne, V., Lesne, T., Lutfalla, G., Herrmann, J. -L., Kremer, L. In vivo assessment of drug efficacy against Mycobacterium abscessus using the embryonic zebrafish test system. Antimicrobial Agents and Chemotherapy. 58, (7), 4054-4063 (2014).
18. Oh, C. -T., Moon, C., Jeong, M. S., Kwon, S. -H., Jang, J. Drosophila melanogaster for Mycobacterium abscessus infection. Microbes and Infection/Institut Pasteur. 15, (12), 788-795 (2013).
19. Bernut, A., Herrmann, J. -L., et al. Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation. Proceedings of the National Academy of Sciences of the United States of America. 111, (10), E943-E952 (2014).
20. Dubée, V., Bernut, A., et al. β-Lactamase inhibition by avibactam in Mycobacterium abscessus. Journal of Antimicrobial Chemotherapy. 70, (4), 1051-1058 (2015).
21. Torraca, V., Masud, S., Spaink, H. P., Meijer, A. H. Macrophage-pathogen interactions in infectious diseases: new therapeutic insights from the zebrafish host model. Disease Models Mechanisms. 7, (7), 785-797 (2014).
22. Alibaud, L., Rombouts, Y., et al. A Mycobacterium marinum TesA mutant defective for major cell wall-associated lipids is highly attenuated in Dictyostelium discoideum and zebrafish embryos. Molecular Microbiology. 80, (4), 919-934 (2011).
23. Clay, H., Volkman, H. E., Ramakrishnan, L. Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity. 29, (2), 283-294 (2008).
24. Palha, N., Guivel-Benhassine, F., et al. Real-time whole-body visualization of Chikungunya Virus infection and host interferon response in zebrafish. PLoS pathogens. 9, (9), e1003619 (2013).
25. Mostowy, S., Boucontet, L., et al. The zebrafish as a new model for the in vivo study of Shigella flexneri with phagocytes and bacterial autophagy. PLoS pathogens. 9, (9), e1003588 (2013).
26. Prajsnar, T. K., Cunliffe, V. T., Foster, S. J., Renshaw, S. A. A novel vertebrate model of Staphylococcus aureus reveals phagocyte-dependent resistance of zebrafish to non-host specialized pathogens. Cellular Microbiology. 10, (11), 2312-2325 (2008).
27. Van der Sar, A. M., Appelmelk, B. J., Vandenbroucke-Grauls, C. M. J. E., Bitter, W. A star with stripes: zebrafish as an infection model. Trends in Microbiology. 12, (10), 451-457 (2004).
28. Vergunst, A. C., Meijer, A. H., Renshaw, S. A., O’Callaghan, D. Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection. Infection and Immunity. 78, (4), 1495-1508 (2010).
29. Levraud, J. -P., Disson, O., et al. Real-time observation of Listeria monocytogenes-phagocyte interactions in living zebrafish larvae. Infection and Immunity. 77, (9), 3651-3660 (2009).
30. Meijer, A. H., Spaink, H. P. Host-pathogen interactions made transparent with the zebrafish model. Current Drug Targets. 12, (7), 1000-1017 (2011).
31. Westerfield, M. The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Danio Rerio). (2007).
32. Benard, E. L., van der Sar, A. M., Ellett, F., Lieschke, G. J., Spaink, H. P., Meijer, A. H. Infection of zebrafish embryos with intracellular bacterial pathogens. Journal of Visualized Experiments. (61), e3781 (2012).
33. Van Rooijen, N., Sanders, A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. Journal of Immunological Methods. 174, (1-2), 83-93 (1994).
34. Adams, K. N., Takaki, K., et al. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell. 145, (1), 39-53 (2011).
35. Ramakrishnan, L. Looking within the zebrafish to understand the tuberculous granuloma. Advances in Experimental Medicine and Biology. 783, 251-266 (2013).
36. Davis, J. M., Clay, H., Lewis, J. L., Ghori, N., Herbomel, P., Ramakrishnan, L. Real-time visualization of Mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity. 17, (6), 693-702 (2002).
37. Lamason, R. L., Mohideen, M. -A. P. K., et al. SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans. Science (New York, NY). 310, (5755), 1782-1786 (2005).
38. Renshaw, S. A., Loynes, C. A., Trushell, D. M. I., Elworthy, S., Ingham, P. W., Whyte, M. K. B. A transgenic zebrafish model of neutrophilic inflammation. Blood. 108, (13), 3976-3978 (2006).
39. Hall, C., Flores, M. V., Storm, T., Crosier, K., Crosier, P. The zebrafish lysozyme C promoter drives myeloid-specific expression in transgenic fish. BMC developmental biology. 7, 42 (2007).
40. Takaki, K., Davis, J. M., Winglee, K., Ramakrishnan, L. Evaluation of the pathogenesis and treatment of Mycobacterium marinum in zebrafish. Nature Protocols. 8, (6), 1114-1124 (2013).
41. Stoop, E. J. M., Schipper, T., et al. Zebrafish embryo screen for mycobacterial genes involved in the initiation of granuloma formation reveals a newly identified ESX-1 component. Disease Models Mechanisms. 4, (4), 526-536 (2011).
42. Carvalho, R., de Sonneville, J., et al. A high-throughput screen for tuberculosis progression. PloS One. 6, (2), e16779 (2011).